Louisiana State Employees Retirement System Takes $1.66 Million Position in Integer Holdings Co. (NYSE:ITGR)

Louisiana State Employees Retirement System purchased a new stake in shares of Integer Holdings Co. (NYSE:ITGR) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 16,700 shares of the medical equipment provider’s stock, valued at approximately $1,655,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Cerity Partners LLC bought a new position in shares of Integer during the 4th quarter valued at $208,000. Wakefield Asset Management LLLP grew its stake in Integer by 11.2% in the 4th quarter. Wakefield Asset Management LLLP now owns 9,796 shares of the medical equipment provider’s stock valued at $971,000 after buying an additional 990 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. grew its stake in Integer by 6.2% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 17,505 shares of the medical equipment provider’s stock valued at $1,734,000 after buying an additional 1,016 shares during the last quarter. Trust Point Inc. acquired a new position in Integer in the 4th quarter valued at $874,000. Finally, LVZ Inc. acquired a new position in Integer in the 4th quarter valued at $239,000. Institutional investors own 99.29% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently issued reports on ITGR. Benchmark raised their target price on shares of Integer from $105.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, March 28th. Bank of America upgraded shares of Integer from a “neutral” rating to a “buy” rating and raised their target price for the company from $105.00 to $135.00 in a research note on Monday, April 15th. CL King began coverage on shares of Integer in a research note on Thursday, March 14th. They issued a “buy” rating and a $137.00 target price on the stock. Finally, KeyCorp raised their target price on shares of Integer from $123.00 to $139.00 and gave the company an “overweight” rating in a research note on Tuesday, April 9th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $120.50.

Integer Stock Performance

NYSE ITGR opened at $116.58 on Friday. The company has a debt-to-equity ratio of 0.64, a current ratio of 2.80 and a quick ratio of 1.71. The firm has a market capitalization of $3.91 billion, a price-to-earnings ratio of 43.34, a P/E/G ratio of 1.64 and a beta of 1.10. The company’s fifty day moving average is $111.82 and its two-hundred day moving average is $98.49. Integer Holdings Co. has a 52-week low of $69.40 and a 52-week high of $121.53.

Integer (NYSE:ITGR) last released its quarterly earnings data on Thursday, February 15th. The medical equipment provider reported $1.39 EPS for the quarter, topping analysts’ consensus estimates of $1.34 by $0.05. The company had revenue of $413.15 million during the quarter, compared to the consensus estimate of $409.04 million. Integer had a net margin of 5.68% and a return on equity of 10.80%. The firm’s revenue for the quarter was up 10.9% compared to the same quarter last year. During the same period last year, the firm earned $1.11 EPS. Equities research analysts forecast that Integer Holdings Co. will post 5.3 EPS for the current year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.